Laboratory Corporation of America Holdings Asset Resilience Ratio
Laboratory Corporation of America Holdings asset resilience ratio. Laboratory Corporation of America Holdings (LH) has an Asset Resilience Ratio of 2.89% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See LH days of operational coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Laboratory Corporation of America Holdings (2004–2025)
Asset resilience ratio of Laboratory Corporation of America Holdings from 2004 to 2025. This chart shows how Laboratory Corporation of America Holdings's Asset Resilience Ratio has changed over time. Read Laboratory Corporation of America Holdin (LH) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Laboratory Corporation of America Holdings's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Laboratory Corporation of America Holdin assets under control.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $532.30 Million | 2.89% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $532.30 Million | 2.89% |
Asset Resilience Insights
- Limited Liquidity: Laboratory Corporation of America Holdings maintains only 2.89% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Laboratory Corporation of America Holdings Industry Peers by Asset Resilience Ratio
Compare Laboratory Corporation of America Holdings's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Revvity Inc.
NYSE:RVTY |
Diagnostics & Research | 0.00% |
|
Wuhan Thalys Med Tech Co Ltd
SHG:603716 |
Diagnostics & Research | 0.16% |
|
JOONGANG DNM Co.Ltd
KQ:051980 |
Diagnostics & Research | 27.26% |
|
Shanghai Rendu Biotechnology Co. Ltd. A
SHG:688193 |
Diagnostics & Research | 70.50% |
|
Krsnaa Diagnostics Limited
NSE:KRSNAA |
Diagnostics & Research | 9.90% |
|
Sonic Healthcare Ltd
AU:SHL |
Diagnostics & Research | 0.13% |
|
Integral Diagnostics Ltd
AU:IDX |
Diagnostics & Research | 0.03% |
|
Australian Clinical Labs Ltd
AU:ACL |
Diagnostics & Research | 4.11% |
Laboratory Corporation of America Holdings Asset Resilience Ratio by Year (2004–2025)
Laboratory Corporation of America Holdings asset resilience ratio by year from 2004 to 2025. The table below shows the annual Asset Resilience Ratio data for Laboratory Corporation of America Holdings.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 2.89% | $532.30 Million | $18.39 Billion | -5.37pp |
| 2024-12-31 | 8.26% | $1.52 Billion | $18.38 Billion | +5.05pp |
| 2023-12-31 | 3.21% | $536.80 Million | $16.73 Billion | +1.08pp |
| 2022-12-31 | 2.13% | $430.00 Million | $20.16 Billion | -5.14pp |
| 2021-12-31 | 7.28% | $1.48 Billion | $20.39 Billion | +0.33pp |
| 2020-12-31 | 6.94% | $1.39 Billion | $20.07 Billion | +5.02pp |
| 2019-12-31 | 1.92% | $346.60 Million | $18.02 Billion | -0.71pp |
| 2018-12-31 | 2.64% | $426.80 Million | $16.19 Billion | +0.73pp |
| 2017-12-31 | 1.91% | $316.60 Million | $16.57 Billion | -1.13pp |
| 2016-12-31 | 3.04% | $433.60 Million | $14.25 Billion | -- |
| 2015-12-31 | 0.00% | $0.00 | $14.29 Billion | -- |
| 2014-12-31 | 0.00% | $0.00 | $7.30 Billion | -- |
| 2013-12-31 | 0.00% | $0.00 | $6.95 Billion | -- |
| 2012-12-31 | 0.00% | $0.00 | $6.81 Billion | -- |
| 2011-12-31 | 0.00% | $0.00 | $6.17 Billion | -- |
| 2009-12-31 | 0.00% | $0.00 | $4.86 Billion | -- |
| 2008-12-31 | 1.54% | $72.00 Million | $4.67 Billion | -0.97pp |
| 2007-12-31 | 2.52% | $109.90 Million | $4.37 Billion | -0.87pp |
| 2006-12-31 | 3.38% | $135.40 Million | $4.00 Billion | +2.93pp |
| 2005-12-31 | 0.46% | $17.70 Million | $3.88 Billion | -0.10pp |
| 2004-12-31 | 0.56% | $20.00 Million | $3.60 Billion | -- |
About Laboratory Corporation of America Holdings
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcoh… Read more